Gonorrhea

Gonococcal Isolate Surveillance Project (GISP) Profiles 2015

AR Investment Map This interactive tool shows CDC’s key investments to combat antibiotic resistance (AR), including resistant gonorrhea, across the nation.

Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance – The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014 MMWR July 14, 2016

Antimicrobial-Resistant Gonorrhea Infographics(https://www.cdc.gov/std/products/infographics.htm) (July 14, 2016)

De-Duplication Guidance for Gonorrhea and Chlamydia Laboratory Reports(https://www.cdc.gov/std/laboratory/de-duplication-guidance-june2016.pdf) – This document contains background and guidance on the timeframe that jurisdictions should use to de-duplicate their gonorrhea and chlamydia laboratory reports before reporting these cases to CDC.(June 17, 3016)

2015 STD Treatment Guidelines – Gonococcal Infections(https://www.cdc.gov/std/tg2015/gonorrhea.htm) – Includes alternative treatment regimens and updated testing recommendations for gonococcal infections, as well as diagnosis, prevention, and special considerations. (June 4, 2015)

Recommendations for the Laboratory-Based Detection of Chlamydia trachomatis and Neisseria gonorrhoeae — 2014(https://www.cdc.gov/std/laboratory/2014labrec/default.htm) (March 14, 2014)

STD Surveillance Case Definitions(https://www.cdc.gov/std/stats/casedefinitions-2014.pdf) – Includes updated definitions for Gonorrhea and Syphilis effective January 1, 2014 (December 10, 2013)

Changes to Gonorrhea and Syphilis Case Definitions: Program Impact(https://www.cdc.gov/std/stats/casedef-programimpact-2014.pdf) (January 16, 2014)